﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Advanced Pharmaceutical Bulletin</JournalTitle>
      <Issn>2228-5881</Issn>
      <Volume>14</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>03</Month>
        <DAY>07</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Low-Affinity NMDA Receptor Antagonist Hemantane in a Topical Formulation Attenuates Arthritis Induced by Freund’s Complete Adjuvant in Rats</ArticleTitle>
    <FirstPage>241</FirstPage>
    <LastPage>252</LastPage>
    <ELocationID EIdType="doi">10.34172/apb.2024.002</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Elena</FirstName>
        <LastName>Ivanova</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-4961-2051</Identifier>
      </Author>
      <Author>
        <FirstName>Alexander</FirstName>
        <LastName>Matyushkin</LastName>
      </Author>
      <Author>
        <FirstName>Alexandra</FirstName>
        <LastName>Sorokina</LastName>
      </Author>
      <Author>
        <FirstName>Svetlana</FirstName>
        <LastName>Alexeeva</LastName>
      </Author>
      <Author>
        <FirstName>Irina</FirstName>
        <LastName>Miroshkina</LastName>
      </Author>
      <Author>
        <FirstName>Kirill</FirstName>
        <LastName>Kachalov</LastName>
      </Author>
      <Author>
        <FirstName>Tatyana</FirstName>
        <LastName>Voronina</LastName>
      </Author>
      <Author>
        <FirstName>Andrey</FirstName>
        <LastName>Durnev</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/apb.2024.002</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>06</Month>
        <Day>08</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>07</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <Abstract>Purpose: N-methyl-D-aspartate (NMDA) receptors that are expressed by T-cells modulate T-cell proliferation, cytotoxicity and cell migration toward chemokines. Several studies have shown an anti-inflammatory effect of NMDA receptor antagonists. This study compares the effect of the noncompetitive low-affinity NMDA receptor antagonist N-(2-adamantyl)-hexamethyleneimine hydrochloride (hemantane) in a topical formulation (gel) with the cyclooxygenase (COX) inhibitor diclofenac in a topical formulation (gel) in rats with arthritis induced by Freund’s Complete Adjuvant (FCA). Methods: On day 14 after an FCA injection into the left hind paw, rats with contralateral hind paw edema were selected for further investigation (29/65). They were treated with 5% hemantane gel or 1% diclofenac gel applied locally to hind paws daily for 2 weeks starting 14 days after the FCA injection. Rats with arthritis were examined hind paw edema, hyperalgesia, and motor deficits; their body weight and hematological parameters were recorded. The rats were euthanized on day 28, followed by histological examination of the ankle joint (HE stain). Results: Rats with arthritis exhibited hind paw inflammation and hyperalgesia, motor deficits, changes of hematological parameters, reduced weight gain and spleen hypertrophy. Histological examination of the ankle joint revealed degenerative-dystrophic lesions of the cartilaginous tissue, proliferative inflammation of the synovium, edema and lymphocytic/macrophage infiltration of periarticular tissues. Hemantane gel reduced hind paw edema, pain, motor deficits and histological signs of inflammation; its effect was comparable to diclofenac gel. Conclusion: Hemantane gel alleviates FCA-induced arthritis in rats, and its effect is comparable to diclofenac gel.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Freund’s Adjuvant</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Inflammation</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">NMDA receptor</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Rats</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Topical formulation</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>